Tourmaline Bio Newsroom

Leerink Partners Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $49

Futu NewsDec 12 15:32

Cantor Fitzgerald Reiterates Overweight on Tourmaline Bio, Maintains $25 Price Target

BenzingaDec 12 00:25

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsDec 11 21:31

H.C. Wainwright Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $49

Futu NewsDec 11 19:31

Strategic Developments in Tourmaline Bio's Cardiovascular Programs Drive Buy Rating

TipRanksDec 11 19:28

UBS Raises Price Target on Tourmaline Bio to CA$73 From CA$70, Maintains Neutral Rating

MT NewswiresDec 9 22:05

Tourmaline Bio Initiated at Outperform by BMO Capital

Dow JonesDec 6 19:28

Tourmaline Bio Price Target Announced at $50.00/Share by BMO Capital

Dow JonesDec 6 19:28

Tourmaline Bio Analyst Ratings

BenzingaDec 6 19:18

BMO Capital Initiates Tourmaline Bio(TRML.US) With Buy Rating, Announces Target Price $50

Futu NewsDec 6 05:31

Piper Sandler Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $65

Futu NewsNov 22 20:33

Analysts' Top Healthcare Picks: Neumora Therapeutics, Inc. (NMRA), Tourmaline Bio (TRML)

TipRanksNov 22 19:57

H.C. Wainwright Maintains Tourmaline Bio(TRML.US) With Buy Rating, Raises Target Price to $49

Futu NewsNov 12 01:31

Guggenheim Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsNov 5 02:31

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsNov 4 20:35

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 25 19:31

Piper Sandler Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $65

Futu NewsOct 17 19:31

Cantor Fitzgerald Initiates Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 15 21:33

Guggenheim Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 12 08:31

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Futu NewsOct 11 19:36